Alkermes plc’s recent filing unveils that its EVP R&D, Chief Medical Officer Hopkinson Craig C. unloaded Company’s shares for reported $0.29 million on Dec 05 ’24. In the deal valued at $31.50 per share,9,221 shares were sold. As a result of this transaction, Hopkinson Craig C. now holds 59,730 shares worth roughly $1.88 million.
Then, Hopkinson Craig C. bought 9,221 shares, generating $290,462 in total proceeds.
Before that, Hopkinson Craig C. sold 14,349 shares. Alkermes plc shares valued at $441,550 were divested by the EVP R&D, Chief Medical Officer at a price of $30.77 per share. As a result of the transaction, Hopkinson Craig C. now holds 68,951 shares, worth roughly $2.17 million.
Stifel upgraded its Alkermes plc [ALKS] rating to a Buy from a a Hold in a research note published on November 05, 2024; the price target was increased to $36 from $25. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Robert W. Baird began covering ALKS with “an Outperform” recommendation on March 19, 2024. UBS revised its rating on February 20, 2024. It rated ALKS as “a Sell” which previously was an “a Neutral”.
Price Performance Review of ALKS
On Friday, Alkermes plc [NASDAQ:ALKS] saw its stock jump 0.87% to $31.46. Over the last five days, the stock has gained 8.41%. Alkermes plc shares have risen nearly 13.41% since the year began. Nevertheless, the stocks have risen 19.12% over the past one year. While a 52-week high of $32.88 was reached on 02/16/24, a 52-week low of $22.90 was recorded on 07/10/24. SMA at 50 days reached $28.29, while 200 days put it at $26.63.
Levels Of Support And Resistance For ALKS Stock
The 24-hour chart illustrates a support level at 31.01, which if violated will result in even more drops to 30.55. On the upside, there is a resistance level at 31.96. A further resistance level may holdings at 32.45. The Relative Strength Index (RSI) on the 14-day chart is 69.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.03, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.04%. Stochastics %K at 92.23% indicates the stock is a selling.
How much short interest is there in Alkermes plc?
A steep rise in short interest was recorded in Alkermes plc stocks on 2024-11-15, growing by 0.74 million shares to a total of 16.56 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 15.82 million shares. There was a rise of 4.47%, which implies that there is a positive sentiment for the stock.
